J. Davignon

3.1k total citations
88 papers, 2.4k citations indexed

About

J. Davignon is a scholar working on Immunology, Epidemiology and Surgery. According to data from OpenAlex, J. Davignon has authored 88 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 21 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in J. Davignon's work include Cytomegalovirus and herpesvirus research (20 papers), Immune Cell Function and Interaction (18 papers) and Lipoproteins and Cardiovascular Health (16 papers). J. Davignon is often cited by papers focused on Cytomegalovirus and herpesvirus research (20 papers), Immune Cell Function and Interaction (18 papers) and Lipoproteins and Cardiovascular Health (16 papers). J. Davignon collaborates with scholars based in France, United States and Canada. J. Davignon's co-authors include Arnaud Constantin, Michel Baron, Alain Cantagrel, Jean‐Frédéric Boyer, Christian Davrinche, Robert A. Eisenberg, Rémy Poupot, Pierre‐Antoine Gourraud, Myriam Hayder and Yannick Degboé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Immunology.

In The Last Decade

J. Davignon

87 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Davignon France 26 995 669 475 475 329 88 2.4k
Efstratios Stratikos Greece 34 1.1k 1.1× 1.2k 1.8× 667 1.4× 399 0.8× 274 0.8× 99 3.2k
Christian Becker Germany 32 2.3k 2.3× 950 1.4× 330 0.7× 125 0.3× 253 0.8× 82 4.0k
Michael York United States 25 628 0.6× 419 0.6× 258 0.5× 276 0.6× 89 0.3× 40 2.6k
John J. Rinehart United States 27 568 0.6× 1.0k 1.5× 241 0.5× 64 0.1× 132 0.4× 67 2.9k
Hanshi Xu China 30 568 0.6× 1.0k 1.5× 195 0.4× 727 1.5× 170 0.5× 80 2.4k
Thomas Ahrens United States 18 926 0.9× 999 1.5× 184 0.4× 174 0.4× 179 0.5× 31 2.5k
Nick Giannoukakis United States 29 1.3k 1.3× 1.2k 1.8× 182 0.4× 65 0.1× 923 2.8× 78 3.3k
Noriaki Inamura Japan 26 807 0.8× 1.3k 1.9× 196 0.4× 158 0.3× 254 0.8× 58 3.0k
Xavier Clemente‐Casares Canada 16 1.1k 1.1× 608 0.9× 176 0.4× 60 0.1× 275 0.8× 31 2.0k

Countries citing papers authored by J. Davignon

Since Specialization
Citations

This map shows the geographic impact of J. Davignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Davignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Davignon more than expected).

Fields of papers citing papers by J. Davignon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Davignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Davignon. The network helps show where J. Davignon may publish in the future.

Co-authorship network of co-authors of J. Davignon

This figure shows the co-authorship network connecting the top 25 collaborators of J. Davignon. A scholar is included among the top collaborators of J. Davignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Davignon. J. Davignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davignon, J., Bernard Combe, & Alain Cantagrel. (2021). Cytomegalovirus infection: friend or foe in rheumatoid arthritis?. Arthritis Research & Therapy. 23(1). 16–16. 11 indexed citations
2.
Briand‐Mésange, Fabienne, Véronique Pons, Sophie Allart, et al.. (2020). Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch. Journal of Biological Chemistry. 295(46). 15767–15781. 11 indexed citations
3.
Davignon, J., Benjamin Rauwel, Yannick Degboé, et al.. (2018). Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review. Arthritis Research & Therapy. 20(1). 229–229. 45 indexed citations
4.
Davignon, J., Myriam Hayder, Michel Baron, et al.. (2012). Targeting monocytes/macrophages in the treatment of rheumatoid arthritis. Lara D. Veeken. 52(4). 590–598. 173 indexed citations
5.
6.
Courties, Gabriel, Michel Baron, Jessy Présumey, et al.. (2010). Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis. Arthritis & Rheumatism. 63(3). 681–690. 25 indexed citations
7.
Baron, Michel & J. Davignon. (2008). Inhibition of IFN-γ-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2. The Journal of Immunology. 181(8). 5530–5536. 53 indexed citations
8.
Marcovina, S, Filippo Crea, J. Davignon, et al.. (2007). Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. Journal of Internal Medicine. 261(3). 214–234. 31 indexed citations
9.
Bourgeade‐Delmas, Sandra, Laurence Martin, Michel Baron, et al.. (2005). Optimization of CD4+ T Lymphocyte Response to Human Cytomegalovirus Nuclear IE1 Protein through Modifications of Both Size and Cellular Localization. The Journal of Immunology. 175(10). 6812–6819. 7 indexed citations
10.
Davignon, J., et al.. (2005). Human Cytomegalovirus-Specific CD4 + T-Cell Clones Recognize Cross-Reactive Peptides From the Immediate Early 1 Protein. Viral Immunology. 18(2). 391–396. 1 indexed citations
11.
Rohrlich, Pierre‐Simon, Sylvain Cardinaud, Félix A. Montero‐Julian, et al.. (2004). Use of a lentiviral vector encoding a HCMV-Chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8+ cytotoxic T cells from human peripheral blood cells. Human Immunology. 65(5). 514–522. 19 indexed citations
12.
13.
Carmena, Rafael, Madeleine Roy, Ghislaine O. Roederer, Anne Minnich, & J. Davignon. (2000). Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Atherosclerosis. 148(1). 113–124. 22 indexed citations
14.
Davignon, J., M Hanefeld, Noriaki Nakaya, et al.. (1998). Clinical efficacy and safety of cerivastatin: summary of pivotal Phase IIb/III studies. The American Journal of Cardiology. 82(4). 32J–39J. 29 indexed citations
15.
Prieur, Eric, Bernard Monsarrat, Honoré Mazarguil, et al.. (1996). Characterization of an epitope of the human cytomegalovirus protein IE1 recognized by a CD4+ T cell clone. European Journal of Immunology. 26(5). 1110–1117. 10 indexed citations
16.
Davignon, J., et al.. (1995). Analysis of the Proliferative T Cell Response to Human Cytomegalovirus Major Immediate‐Early Protein (IEl): Phenotype, Frequeney and Variability*. Scandinavian Journal of Immunology. 41(3). 247–255. 30 indexed citations
17.
Gagné, C, Pierre Julien, M.R.V. Murthy, et al.. (1993). Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of Quebec.. PubMed. 65(1). 29–39. 10 indexed citations
18.
Gagné, C, Pierre Julien, M Lambert, et al.. (1992). Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada).. PubMed. 35(2). 89–92. 5 indexed citations
19.
Davignon, J., Philip L. Cohen, & Robert A. Eisenberg. (1988). Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp- lpr/lpr mice.. The Journal of Immunology. 141(6). 1848–1854. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Efstratios Stratikos Breakdown of academic impact, for papers by Christian Becker Breakdown of academic impact, for papers by Michael York Breakdown of academic impact, for papers by John J. Rinehart Breakdown of academic impact, for papers by Hanshi Xu Breakdown of academic impact, for papers by Thomas Ahrens Breakdown of academic impact, for papers by Nick Giannoukakis Breakdown of academic impact, for papers by Noriaki Inamura Breakdown of academic impact, for papers by Xavier Clemente‐Casares
Rankless by CCL
2026